Visit for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 

Once or Twice Daily versus Three Times Daily Amoxicillin With or Without Clavulanate for the Treatment of Acute Otitis Media

Description of Resource: 
Acute middle ear infection (acute otitis media) is a very common disease in children and may cause pain and hearing loss. Delayed or ineffective treatment may lead to serious complications such as eardrum perforation, sensorineural hearing loss or the disease becoming chronic. Amoxicillin, with or without Clavulanate, is the most commonly used antibiotic for treating acute otitis media. To aid compliance, the dosing interval has been reduced to 1 or 2 daily doses from the conventional 3 or 4. This systematic review sought to assess the evidence for this change in recommendation and identified 5 randomized clinical trials comparing the 2 dosing schedules. Results showed that treating acute middle ear infection with both dosing schedules, with or without Clavulanate, have the same results.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
Cochrane Review
Developer Type: 
Non-Federal Government
Healthy People 2020 Topic Area(s): 
Hearing and Other Sensory or Communication Disorders
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Thanaviratananich S, Laopaiboon M, Vatanasapt P. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Cochrane Database Syst Rev [Internet]. 2013 [cited 2017 Dec 29];(12). Art. No.: CD004975. doi: 10.1002/14651858.CD004975.pub3. Available from: